There’s No Getting Around Mannkind Corp (NASDAQ: MNKD) Success

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.

Stocks Info

As a NASDAQ listed company, MNKD falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Mannkind Corp is $1.54B. A total of 1.12 million shares were traded on the day, compared to an average of 2.61M shares.

In the most recent transaction, Binder Steven B. sold 67,536 shares of MNKD for 6.89 per share on Nov 22 ’24. After the transaction, the Director now owns 1,075,026 company shares. In a previous transaction on Nov 22 ’24, STEVEN B BINDER bought 67,536 shares at 6.89 per share.

Among the insiders who sold shares, Binder Steven B. disposed of 67,539 shares on Nov 15 ’24 at a per-share price of $6.76. This resulted in the Director holding 1,075,026 shares of MNKD after the transaction. In another insider transaction, STEVEN B BINDER bought 67,539 shares at $6.76 per share on Nov 15 ’24.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, MNKD has a high of $7.63 and a low of $3.38.

As of this writing, MNKD has an earnings estimate of $0.03 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of $0.03 per share and a lower estimate of $0.03.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. MNKD’s latest balance sheet shows that the firm has $204.12M in Cash & Short Term Investments as of fiscal 2021. There were $282.24M in debt and $48.35M in liabilities at the time. Its Book Value Per Share was -$0.76, while its Total Shareholder’s Equity was -$209.35M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MNKD is Buy with a score of 4.88.

Most Popular

Related Posts